Cardiac intensive care units have evolved rapidly in recent years. Drs Barsness and Acharya discuss unique training and resource requirements for a model CICU.
How do you bring order to the chaos in the aftermath of a mass shooting? Dr Rob Glatter speaks with Dr Dale Carrison, chief of emergency medicine at UMC in Las Vegas.
Dr Andrew Shorr reports on promising data suggesting that broad-spectrum antibiotics reduce mortality, but will overly broad therapy cause antibiotic resistance?
Is CMV just a bystander or is it a contributor to critical illness in non-immunosuppressed ICU patients? A new study provides a few answers and raises new questions.
Many factors have contributed to physicians' disillusionment with medicine--E&M coding, tsunamis of paperwork--but among these, the EHR stands out as particularly egregious.
Dr Paul Auwaerter addresses some misunderstandings about the management of Clostridium difficile infection that he discovered during his time on a consultation service.
Although they aren't FDA-approved yet, high-sensitivity troponin assays may soon replace traditional troponin assays for detecting acute MIs. Drs Gulati and Jaffe discuss the implications.
New attention to sepsis including revised definitions, updated guidelines, and new CMS reporting requirements aims to save lives through prevention and prompt and effective management of infections.
Dr Wharton quotes baseball legend Yogi Berra in this narrated case: In theory there is no difference between theory and practice. In practice there is.
Dr Goldhaber reviews a meta-analysis he coauthored of RE-COVER trial data suggesting that new oral anticoagulants may be a better option than warfarin for treating acute VTE.
Dr Amy Pollak talks to Dr William Haley of the Mayo Clinic about how to interpret the results from the SPRINT trial and why practitioners should stay tuned for further results.
'Whatever it takes,' says Dr Jeffrey Berns, we need to get patients with advanced kidney disease into the care of a nephrologist before dialysis is initiated to reduce mortality during the first year.
Zubin Damania, an internist and rapper/singer who performs musical parodies under the name ZDoggMD, talks with Eric Topol about his love for Weird Al and his novel medical practice, Turntable Health.
Does 24 months of anticoagulation therapy after unprovoked PE result in better outcomes than 6 months of treatment? Dr Andrew Shorr analyzes the PADIS-PE trial.
Eric Topol speaks with author Siddhartha Mukherjee about his latest book, The Laws of Medicine, and how uncertainty, imperfections, priors, outliers, and biases affect these laws.
Dr Leana Wen, city health commissioner for Baltimore, speaks with Medscape Editor-in-Chief Dr Eric Topol about her work as an emergency medicine physician and public health advocate.
Dr Goldhaber interviews Dr Pollack about the REVERSE-AD study evaluating a new dabigatran reversal agent and what the future holds for other NOAC reversal agents.